After a relatively flat start, activity picked up in the second half of the year with a flurry of sizeable transactions announced including AbbVie's acquisitions..

The Patent Re-examination Board of China's National Intellectual Property Administration (PRB) recently issued a decision to invalidate two "orange book" patents..

On February 23, 2024, the FDA approved Alvotech and Teva's Simlandi® (adalimumab-ryvk) as biosimilar to and interchangeable with AbbVie's Humira® (adalimumab)...

In a patent infringement action brought by Allergan and AbbVie under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations..

Allergan and Abbvie brought this action under the PM(NOC) Regulations, seeking to prevent the issuance of a Notice of Compliance for Juno Pharmaceuticals'..

Our readers may recall that ten HUMIRA biosimilars have been licensed to launch, with Amgen's AMJEVITA the only one to launch to date and nine others set to..

Last week, AbbVie held its third quarter 2022 earnings conference call, which included considerable discussion of forthcoming competition with biosimilars to..

The Federal Court recently denied AbbVie's application for judicial review of two decisions of the Minister of Health (the Minister) relating to JAMP Pharma's..

*Great Place to Work^*, the global authority on workplace culture, surveyed over 3.3 million employees from across 16 diverse countries and cultures in Asia and..

Abbvie Inc said on Wednesday it is partnering with Danish biotech firm Genmab AS to jointly develop and market cancer treatments, as it looks to expand its..

Abbvie Inc said on Wednesday it is partnering with Danish biotech firm Genmab AS to jointly develop and market cancer treatments, as it looks to expand its..

Abbvie Inc said on Wednesday it has entered into an agreement with Genmab AS to jointly develop and commercialize cancer treatment.

U.S. drugmaker AbbVie Inc said on Friday it would develop an antibody therapy to prevent and treat COVID-19 in partnership with three organizations including the..

The U.S. Food and Drug Administration on Friday approved Abbvie Inc's oral treatment for managing heavy menstrual bleeding associated with fibroids in..

The U.S. Food and Drug Administration on Friday approved Abbvie Inc's oral treatment for managing heavy menstrual bleeding associated with fibroids in..

Drugmaker AbbVie Inc has won U.S. antitrust approval to buy Botox maker Allergan , a blockbuster $63 billion deal when it was announced last year, the companies..